Successful use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease
Published: 12 March 2024| Version 1 | DOI: 10.17632/g7tz37rgsb.1
Contributor:
Mary Grace HrenDescription
Supplemental data describing patient demographics and characteristics from our dataset.
Files
Institutions
Icahn School of Medicine at Mount Sinai
Categories
Dermatology